BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 27088920)

  • 1. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.
    Dieu-Nosjean MC; Giraldo NA; Kaplon H; Germain C; Fridman WH; Sautès-Fridman C
    Immunol Rev; 2016 May; 271(1):260-75. PubMed ID: 27088920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
    Goc J; Germain C; Vo-Bourgais TK; Lupo A; Klein C; Knockaert S; de Chaisemartin L; Ouakrim H; Becht E; Alifano M; Validire P; Remark R; Hammond SA; Cremer I; Damotte D; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Cancer Res; 2014 Feb; 74(3):705-15. PubMed ID: 24366885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
    Germain C; Gnjatic S; Tamzalit F; Knockaert S; Remark R; Goc J; Lepelley A; Becht E; Katsahian S; Bizouard G; Validire P; Damotte D; Alifano M; Magdeleinat P; Cremer I; Teillaud JL; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Am J Respir Crit Care Med; 2014 Apr; 189(7):832-44. PubMed ID: 24484236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer.
    de Chaisemartin L; Goc J; Damotte D; Validire P; Magdeleinat P; Alifano M; Cremer I; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Cancer Res; 2011 Oct; 71(20):6391-9. PubMed ID: 21900403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients.
    Germain C; Devi-Marulkar P; Knockaert S; Biton J; Kaplon H; Letaïef L; Goc J; Seguin-Givelet A; Gossot D; Girard N; Validire P; Lefèvre M; Damotte D; Alifano M; Lemoine FM; Steele KE; Teillaud JL; Hammond SA; Dieu-Nosjean MC
    Front Immunol; 2021; 12():626776. PubMed ID: 33763071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.
    Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Mantovani A; Marchesi F
    Int Rev Immunol; 2015 Mar; 34(2):123-33. PubMed ID: 25901857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer.
    Sautès-Fridman C; Verneau J; Sun CM; Moreira M; Chen TW; Meylan M; Petitprez F; Fridman WH
    Semin Immunol; 2020 Apr; 48():101406. PubMed ID: 33248905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
    Trüb M; Zippelius A
    Front Immunol; 2021; 12():674565. PubMed ID: 34054861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
    Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
    Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary lymphoid structures in cancer and beyond.
    Dieu-Nosjean MC; Goc J; Giraldo NA; Sautès-Fridman C; Fridman WH
    Trends Immunol; 2014 Nov; 35(11):571-80. PubMed ID: 25443495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLS in Tumors: What Lies Within.
    Sautès-Fridman C; Fridman WH
    Trends Immunol; 2016 Jan; 37(1):1-2. PubMed ID: 26706045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
    Rodriguez AB; Peske JD; Woods AN; Leick KM; Mauldin IS; Meneveau MO; Young SJ; Lindsay RS; Melssen MM; Cyranowski S; Parriott G; Conaway MR; Fu YX; Slingluff CL; Engelhard VH
    Cell Rep; 2021 Jul; 36(3):109422. PubMed ID: 34289373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
    N J; J T; Sl N; Gt B
    Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.
    Weinstein AM; Storkus WJ
    Adv Cancer Res; 2015; 128():197-233. PubMed ID: 26216634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary Lymphoid Structures: An Anti-tumor School for Adaptive Immune Cells and an Antibody Factory to Fight Cancer?
    Teillaud JL; Dieu-Nosjean MC
    Front Immunol; 2017; 8():830. PubMed ID: 28785261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines and cell migration in secondary lymphoid organs.
    Cyster JG
    Science; 1999 Dec; 286(5447):2098-102. PubMed ID: 10617422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tertiary lymphoid structures in cancer: From biology to therapeutic guides].
    Quesada S; Lebreton C; Caux C; Italiano A; Dubois B
    Bull Cancer; 2023 Jun; 110(6):657-664. PubMed ID: 37150731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.
    Germain C; Gnjatic S; Dieu-Nosjean MC
    Front Immunol; 2015; 6():67. PubMed ID: 25755654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune infiltration in human cancer: prognostic significance and disease control.
    Fridman WH; Galon J; Dieu-Nosjean MC; Cremer I; Fisson S; Damotte D; Pagès F; Tartour E; Sautès-Fridman C
    Curr Top Microbiol Immunol; 2011; 344():1-24. PubMed ID: 20512556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.